Ipsen, BioMérieux Partner on Theranostics Approach to Cancer

The collaboration will leverage Ipsen's broad portfolio of compounds and BioMérieux's diagnostic tests and focus on prostate and breast cancers, neuroendocrine tumors, and pituitary tomors.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.